ALYA

Vision 2030 · Healthcare

Saudi Arabia is rebuilding healthcare. Your technology belongs in it.

$1M–$10M in non-dilutive funding from Gulf institutional capital, structured on future product revenue — aligned with the Kingdom's $65 billion health transformation.

See if your technology qualifiesHow it works

The $65 billion shift

The Kingdom set itself a deadline.

Vision 2030 puts healthcare transformation at the center of the largest economic diversification program in the world. For MedTech and BioTech companies, that is not a headline — it is a funded mandate looking for technology to back.

$0B

Directed into healthcare transformation under Vision 2030

0M

People inside the Kingdom's healthcare system today

0

The deadline the Kingdom set itself

Where the need is

The region's disease burden is specific — and underserved.

Diabetes

Adult prevalence in the Gulf runs among the highest in the world. Screening, monitoring and treatment are national priorities with dedicated budgets.

Cardiovascular disease

The leading cause of death in the Kingdom, presenting years earlier than Western averages — and a first-order target of the health transformation.

Hereditary & genomic conditions

High rates of hereditary disease make the Kingdom a global center of genomic medicine — and a natural first market for precision diagnostics.

The capital bridge

Non-dilutive capital, structured on your future revenue.

Alya structures royalty financing: investors fund your trial or launch today in exchange for a defined share of future product revenue. If the product never earns, there is nothing to repay.

  1. 01

    Qualify

    We review stage, clinical data and fit with the region's priorities. A clear yes or no, fast.

  2. 02

    Structure

    Royalty terms are set with securities counsel and issued as regulated digital securities under a Reg S framework, on the ERC-3643 institutional standard.

  3. 03

    Raise

    Your offering is introduced to a verified pool of Gulf institutional investors, with licensed intermediaries wherever required.

  4. 04

    Distribute

    Capital reaches your company; royalty distributions flow to investors only as your revenue arrives.

You keep 100% of your equity, your board and your IP.

Raising $1M–$10M for a trial or a launch?

Nine fields, five minutes, and a clear answer within ten business days.

See if your technology qualifies